Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Nature Reviews. Urology
|
August 15, 2012
Sexual medicine: Why stop a good thing? Discontinuing PDE5 inhibitors
Helen M Conaglen, John V Conaglen
The Journal of Sexual Medicine
|
March 4, 2008
Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: the partners' preference study
Helen M Conaglen, John V Conaglen
Journal of Sex & Marital Therapy
|
September 25, 2003
Sexual desire in women presenting for antiandrogen therapy
Helen M Conaglen, John V Conaglen
The Journal of Sexual Medicine
|
February 14, 2009
The effects of treating male hypogonadism on couples' sexual desire and function
John V Conaglen, Helen M Conaglen
The Journal of Sexual Medicine
|
January 14, 2012
Couples' reasons for adherence to, or discontinuation of, PDE type 5 inhibitors for men with erectile dysfunction at 12 to 24-month follow-up after a 6-month free trial
Helen M Conaglen, John V Conaglen
Journal of Primary Health Care
|
August 10, 2010
A raised thyroid stimulating hormone result--a 12-month follow-up study in general practice
Veronique Gibbons, John V Conaglen, Ross Lawrenson
The New Zealand Medical Journal
|
April 9, 2002
False positive 131I-metaiodobenzylguanidine scan in the postoperative assessment of malignant phaeochromocytoma secondary to medullary hyperplasia
Morton G Burt, Berry Allen, John V Conaglen
The New Zealand Medical Journal
|
October 16, 2009
Do general practitioners use thyroid stimulating hormone assay for opportunistic screening?
Veronique Gibbons, Steven Lillis, John V Conaglen, et al.
Archives of Sexual Behavior
|
June 17, 2003
Effect of deer velvet on sexual function in men and their partners: a double-blind, placebo-controlled study
Helen M Conaglen, James M Suttie, John V Conaglen
Clinical Endocrinology
|
September 27, 2005
Insulinoma localization using hepatic venous sampling with selective arterial calcium stimulation: should a fixed calcium dose be used?
Marianne S Elston, Michael J Swarbrick, John V Conaglen
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Nature Reviews. Urology
|
August 15, 2012
Sexual medicine: Why stop a good thing? Discontinuing PDE5 inhibitors
Helen M Conaglen, John V Conaglen
The Journal of Sexual Medicine
|
March 4, 2008
Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: the partners' preference study
Helen M Conaglen, John V Conaglen
Journal of Sex & Marital Therapy
|
September 25, 2003
Sexual desire in women presenting for antiandrogen therapy
Helen M Conaglen, John V Conaglen
The Journal of Sexual Medicine
|
February 14, 2009
The effects of treating male hypogonadism on couples' sexual desire and function
John V Conaglen, Helen M Conaglen
The Journal of Sexual Medicine
|
January 14, 2012
Couples' reasons for adherence to, or discontinuation of, PDE type 5 inhibitors for men with erectile dysfunction at 12 to 24-month follow-up after a 6-month free trial
Helen M Conaglen, John V Conaglen
Journal of Primary Health Care
|
August 10, 2010
A raised thyroid stimulating hormone result--a 12-month follow-up study in general practice
Veronique Gibbons, John V Conaglen, Ross Lawrenson
The New Zealand Medical Journal
|
April 9, 2002
False positive 131I-metaiodobenzylguanidine scan in the postoperative assessment of malignant phaeochromocytoma secondary to medullary hyperplasia
Morton G Burt, Berry Allen, John V Conaglen
The New Zealand Medical Journal
|
October 16, 2009
Do general practitioners use thyroid stimulating hormone assay for opportunistic screening?
Veronique Gibbons, Steven Lillis, John V Conaglen, et al.
Archives of Sexual Behavior
|
June 17, 2003
Effect of deer velvet on sexual function in men and their partners: a double-blind, placebo-controlled study
Helen M Conaglen, James M Suttie, John V Conaglen
Clinical Endocrinology
|
September 27, 2005
Insulinoma localization using hepatic venous sampling with selective arterial calcium stimulation: should a fixed calcium dose be used?
Marianne S Elston, Michael J Swarbrick, John V Conaglen
Page
of 5